Report Overview
-
Request a Free Sample to learn more about this report
The global Hyperpigmentation Treatment Market size was USD 419.8 million in 2021. The global COVID-19 pandemic has been unprecedented and staggering, with Hyperpigmentation Treatment Market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. As per our research, the market is expected to reach USD 738.4 million in 2028, exhibiting a CAGR of 8.3% during the forecast period. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.
Pigmentation is the term used to describe regions of the skin that are darker in color than the surrounding skin, frequently giving the area a patchy or uneven look. Freckles and sunspots, melasma or chloasma, seborrheic keratosis, and birthmarks are all examples of pigmentation. Use of ineffective skin care products, ongoing sun exposure, and heat injury can all exacerbate it. Melanocytes in the deeper layers of the skin create melanin, a pigment that darkens the skin, which leads to hyperpigmentation. Disorders of hyperpigmentation are treatable with cosmeceuticals, laser therapy, and chemical peels. The global market for the treatment of hyperpigmentation diseases is also being driven by the rise in melasma prevalence and increased knowledge of hyperpigmentation treatments.
The market for the treatment of hyperpigmentation diseases is being stimulated by the demand for post-inflammatory hyperpigmentation (PIH) treatments. the proportion of people with darker skin colors. There is still an unmet demand in the global market for the treatment of hyperpigmentation disorders, despite the fact that there is a vast body of research on the pathophysiology of PIH. To close this gap, various formulations including hydroquinone, tretinoin, and dexamethasone are being investigated.
COVID-19 Impact: Pandemic Negatively Impacted Market Trends
The market for treating pigmentation disorders has been disrupted by the COVID-19 pandemic. In order to gauge the pandemic's effects, Hamilton Fraser Cosmetic Insurance surveyed 1,360 UK cosmetic specialists in March 2020. According to the survey, the pandemic had an impact on 99.78% of them and their profession. Patients must be triaged during the COVID-19 pandemic to prevent needless hospitalization due to minor injuries and other illnesses. Additionally, it is wise to refrain from bringing patients in for routine check-ups and minor concerns. Although non-urgent clinical and surgical treatments must be delayed until the situation gets better, the hospital must nonetheless ensure the patients receive high-quality care. The market under investigation has been greatly impacted because the majority of cosmetic operations can be considered non-essential.
Latest Trends
"Over the Forecast Period, the Topical Treatment Segment Is Anticipated to Maintain a Sizeable Market Share"
Due to increased clinical results in patients with pigmentation disorders, the topical treatment sector currently rules the global market. The most often given topical medications worldwide are azelaic acid, hydroquinone, L-ascorbic acid, etc. To treat various pigmentation problems, topical treatment comprises using creams, lotions, ointments, and serums topically. A range of active ingredients are used to create these products. According to market trends for treating hyperpigmentation diseases worldwide, melasma prevalence is predicted to climb in the coming years, along with the number of available treatments.
Segmentation
-
Request a Free Sample to learn more about this report
- By Type Analysis
According to type, the market can be segmented into Pharmacological Therapy, Laser Treatment, Chemical Peels and Bleach, Microdermabrasion, Skin Grafting or Plastic Surgery. Pharmacological Therapy will be the leading segment during the forecast period.
- By Application Analysis
Based on application, the market can be divided into Skin Clinics, Drug and Cosmetic Stores, Hypermarkets and Supermarkets. Skin Clinics are anticipated to have the dominant market share.
Driving Factors
"Market Growth Is Being Driven By A Rise In Prevalence of Melasma"
Based on disease indication, the melasma segment held the greatest market share for treatments for hyperpigmentation disorders globally in 2021. Melasma is a symmetrical hyperpigmentation disorder that is primarily acquired and affects the face. Women and those with darker complexion tones are more likely to experience it. Melasma is a common skin disease, particularly in pregnant women. 15% to 50% of expectant mothers have melasma. Melasma commonly manifests during a woman's reproductive years and seldom during adolescence. It can affect 1.5% to 33% of persons. Usually, it starts between the ages of 20 and 40. High demand for dermatological care has resulted from an increase in melasma prevalence and a preference for cosmeceutical treatments. In the United States, melasma affected more than 5 million people in 2020, and it can impact up to 30% of Asian women of reproductive age. It is hard to treat and recurs frequently. Recent years have seen considerable advancements in the pathophysiology, clinical staging & classification, and clinical management of melasma.
"Offering Laser Therapy & Phototherapy to Support Dermatology & Esthetic Clinics"
The segment of aesthetic clinics and dermatology facilities is anticipated to hold the largest market share for the treatment of hyperpigmentation disorders globally during the forecast period. In the near future, the segment is anticipated to be driven by an increase in the number of dermatological and aesthetic clinics. To address the rising demand for treatments for hyperpigmentation disorders, producers and dealers of cosmeceuticals for hyperpigmentation are enhancing their supply chains. A number of firms are being encouraged by other big players and retailers to use an omnichannel supply strategy to get their products to customers.
Restraining Factors
"High Cost Of Cosmetic Procedure Limiting The Market Growth"
During the forecast period, it is projected that the high cost of treatments for pigmentation disorders will prevent more people from using them. Therefore, the market may experience slower growth in low- and middle-income regions.
Regional Insights
-
Request a Free Sample to learn more about this report
"North America to Dominate the Market Forecast during 2022-2028"
Due to the rising prevalence of pigmentation disorders, the region's established healthcare infrastructure, and the presence of major market players offering post-inflammatory hyperpigmentation patients effective treatment options, North America dominates the global market for treating pigmentation disorders. For instance, according to a StatPearls article named "Albinism" that was published in August 2021, the American area has the highest prevalence of albinism (1:36,000). Additionally, according to the same source, the prevalence rate for African Americans is 1:10,000. The rising frequency of albinism in the nation is therefore anticipated to increase demand for treatments for pigmentation disorders, which will further drive market expansion over the forecast period.
Key Industry Players
"Key Players Focus on Partnerships to Gain a Competitive Advantage "
Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.
List of Market Players Profiled
- Biocosmetic Research Labs
- Episciences
- Vivier Pharma
- La Roche-Posay
- Pierre Fabre Dermo Cosmetique
- Bayer
- Alvogen
- Allergan
- Obagi Medical Products
- SkinCeuticals International
- L'oreal Paris
Report Coverage
This research profiles a report with extensive studies that take into description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, and restraints. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.
| REPORT COVERAGE | DETAILS |
|---|---|
| Market Size Value In | US$ 419.8 Million in 2021 |
| Market Size Value By | US$ 738.4 Million by 2028 |
| Growth Rate | CAGR of 8.3% from 2021 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2021 |
| Historical Data Available | Yes |
| Segments Covered | Types & Application |
| Regional Scope | Global |
Frequently Asked Questions
-
What value is the global Hyperpigmentation Treatment Market expected to touch by 2028?
The global Hyperpigmentation Treatment Market is expected to touch USD 738.4 million by 2028.
-
What CAGR is the Hyperpigmentation Treatment market expected to exhibit during 2022-2028?
The Hyperpigmentation Treatment market is expected to exhibit a CAGR of 8.3% over 2022-2028.
-
Which are the driving factors of the Hyperpigmentation Treatment market?
The segment of aesthetic clinics and dermatology facilities is anticipated to hold the largest market share for the treatment of hyperpigmentation disorders globally during the forecast period.
-
Which are the top companies operating in the Hyperpigmentation Treatment market?
Biocosmetic Research Labs (U.K.), Episciences (U.K.), Vivier Pharma (Canada), La Roche-Posay (France), and Pierre Fabre Dermo Cosmetique (France) are among the key Hyperpigmentation Treatment market players.
